Variant report
Variant | nsv1026571 |
---|---|
Chromosome Location | chr7:109606488-109640021 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:62)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:1)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No. | Transcrition factor | Chromosome Location | Cell Line | Cell type | Cell Stage | Matched TF binding sites |
---|---|---|---|---|---|---|
1 | CEBPB | chr7:109611839-109612086 | HepG2 | liver: | n/a | n/a |
2 | CEBPB | chr7:109624910-109625197 | Hela-S3 | cervix: | n/a | n/a |
3 | CEBPB | chr7:109611846-109612084 | IMR90 | lung: | n/a | n/a |
4 | CEBPB | chr7:109611851-109612073 | A549 | lung: | n/a | n/a |
5 | CTCF | chr7:109606520-109606670 | NB4 | blood: | n/a | n/a |
6 | E2F4 | chr7:109629552-109629572 | MCF10A-Er-Src | breast: | n/a | n/a |
7 | E2F4 | chr7:109624340-109625130 | MCF10A-Er-Src | breast: | n/a | chr7:109624611-109624622 |
8 | EP300 | chr7:109623049-109624314 | SK-N-SH | brain: | n/a | chr7:109623206-109623216 chr7:109624024-109624038 chr7:109624014-109624028 chr7:109624018-109624032 |
9 | EP300 | chr7:109623766-109624012 | SK-N-SH_RA | brain: | n/a | n/a |
10 | FOS | chr7:109624759-109625110 | MCF10A-Er-Src | breast: | n/a | n/a |
11 | FOS | chr7:109607485-109607740 | MCF10A-Er-Src | breast: | n/a | chr7:109607627-109607636 chr7:109607627-109607634 |
12 | FOS | chr7:109607518-109607827 | MCF10A-Er-Src | breast: | n/a | chr7:109607627-109607636 chr7:109607627-109607634 |
13 | FOS | chr7:109624737-109625044 | MCF10A-Er-Src | breast: | n/a | n/a |
14 | FOS | chr7:109624844-109625094 | MCF10A-Er-Src | breast: | n/a | n/a |
15 | FOS | chr7:109607520-109607818 | MCF10A-Er-Src | breast: | n/a | chr7:109607627-109607636 chr7:109607627-109607634 |
16 | FOS | chr7:109624673-109625108 | MCF10A-Er-Src | breast: | n/a | n/a |
17 | GATA3 | chr7:109619154-109619308 | SH-SY5Y | brain: | n/a | n/a |
18 | GATA3 | chr7:109623734-109623975 | SH-SY5Y | brain: | n/a | n/a |
19 | GATA3 | chr7:109628784-109628875 | SH-SY5Y | brain: | n/a | chr7:109628786-109628799 |
20 | GATA3 | chr7:109623657-109624192 | SK-N-SH | brain: | n/a | n/a |
21 | JUN | chr7:109617513-109617673 | K562 | blood: | n/a | n/a |
22 | MAFF | chr7:109623818-109624051 | HepG2 | liver: | n/a | n/a |
23 | MAFK | chr7:109607916-109608244 | IMR90 | lung: | n/a | n/a |
24 | MAFK | chr7:109619120-109619323 | HepG2 | liver: | n/a | n/a |
25 | MAFK | chr7:109623760-109624059 | HepG2 | liver: | n/a | n/a |
26 | MAFK | chr7:109608055-109608115 | K562 | blood: | n/a | n/a |
27 | MAFK | chr7:109629719-109629993 | HepG2 | liver: | n/a | chr7:109629840-109629851 chr7:109629842-109629859 chr7:109629839-109629850 |
28 | MAFK | chr7:109623786-109624009 | IMR90 | lung: | n/a | n/a |
29 | MAFK | chr7:109607970-109608181 | HepG2 | liver: | n/a | n/a |
30 | MAFK | chr7:109607935-109608264 | HepG2 | liver: | n/a | n/a |
31 | MAX | chr7:109624836-109625203 | Hela-S3 | cervix: | n/a | n/a |
32 | MAX | chr7:109626808-109627000 | H1-hESC | embryonic stem cell: | n/a | n/a |
33 | MAZ | chr7:109606695-109606729 | HepG2 | liver: | n/a | n/a |
34 | MXI1 | chr7:109624832-109625110 | Hela-S3 | cervix: | n/a | n/a |
35 | MYC | chr7:109622227-109622292 | MCF-7 | breast: | n/a | n/a |
36 | MYC | chr7:109610429-109610464 | MCF10A-Er-Src | breast: | n/a | n/a |
37 | NFYB | chr7:109612465-109612627 | GM12878 | blood: | n/a | n/a |
38 | POLR2A | chr7:109639072-109639079 | A549 | lung: | n/a | n/a |
39 | POLR2A | chr7:109608193-109608291 | MCF10A-Er-Src | breast: | n/a | n/a |
40 | POLR2A | chr7:109610739-109610819 | MCF10A-Er-Src | breast: | n/a | n/a |
41 | POLR2A | chr7:109632573-109632635 | MCF10A-Er-Src | breast: | n/a | n/a |
42 | POLR2A | chr7:109639444-109639601 | A549 | lung: | n/a | n/a |
43 | POLR2A | chr7:109622393-109622523 | MCF10A-Er-Src | breast: | n/a | n/a |
44 | POLR2A | chr7:109623281-109623447 | MCF10A-Er-Src | breast: | n/a | n/a |
45 | POLR2A | chr7:109639084-109639097 | A549 | lung: | n/a | n/a |
46 | POLR2A | chr7:109618567-109618767 | MCF10A-Er-Src | breast: | n/a | n/a |
47 | POLR2A | chr7:109620812-109620837 | MCF10A-Er-Src | breast: | n/a | n/a |
48 | POLR2A | chr7:109618234-109618414 | MCF-7 | breast: | n/a | n/a |
49 | POLR2A | chr7:109610745-109610777 | MCF10A-Er-Src | breast: | n/a | n/a |
50 | POLR2A | chr7:109607134-109607434 | MCF10A-Er-Src | breast: | n/a | n/a |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr7:109621845..109625177-chr7:109626649..109628866,3 | K562 | blood: | |
2 | chr7:109617231..109619713-chr7:109622419..109624214,3 | K562 | blood: | |
3 | chr7:109621845..109625177-chr7:109626649..109628866,3 | K562 | blood: | |
4 | chr7:109617231..109619713-chr7:109622419..109624214,3 | K562 | blood: |
(count:1 , 50 per page) page:
1
No. | lncRNA name | Chromosome Location | lncRNA alias |
---|---|---|---|
1 | lnc-IMMP2L-7 | chr7:109638491-109639681 | NONHSAT122757 |
No data |
No data |
Variant related genes | Relation type |
---|---|
RPL3P8 | TF binding region |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs116841698 | chr7:109620606-109620607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs553081107 | chr7:109620661-109620662 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs2523215 | chr7:109620747-109620748 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
4 | rs553058802 | chr7:109620802-109620803 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs142245544 | chr7:109620819-109620820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs555101204 | chr7:109620834-109620835 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs574945711 | chr7:109620840-109620841 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs544061986 | chr7:109620849-109620850 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs577711824 | chr7:109620917-109620918 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs368118899 | chr7:109620954-109620955 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs112851320 | chr7:109620981-109620982 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs563850780 | chr7:109621014-109621015 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374400540 | chr7:109621026-109621027 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs182112133 | chr7:109621053-109621054 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs544981239 | chr7:109621068-109621069 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs143029980 | chr7:109621098-109621099 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs75620012 | chr7:109621147-109621148 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs184381591 | chr7:109621166-109621167 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs2523216 | chr7:109621200-109621201 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
20 | rs112428739 | chr7:109621235-109621236 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs75981615 | chr7:109621236-109621237 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs550823543 | chr7:109621243-109621244 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs2523217 | chr7:109621244-109621245 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs189211380 | chr7:109621245-109621246 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs116897939 | chr7:109621257-109621258 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs34550942 | chr7:109621271-109621272 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs566566668 | chr7:109621272-109621273 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs112960925 | chr7:109621280-109621281 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs555188827 | chr7:109621286-109621287 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs181883275 | chr7:109621298-109621299 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532686431 | chr7:109621300-109621301 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs557619346 | chr7:109621347-109621348 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
33 | rs73433535 | chr7:109621350-109621351 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
34 | rs148182950 | chr7:109621363-109621364 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs140238740 | chr7:109621370-109621371 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs184927883 | chr7:109621383-109621384 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs73195871 | chr7:109621418-109621419 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
38 | rs562061722 | chr7:109621511-109621512 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
39 | rs191196007 | chr7:109621561-109621562 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
40 | rs150323449 | chr7:109621609-109621610 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
41 | rs550534893 | chr7:109621677-109621678 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
42 | rs564360247 | chr7:109621777-109621778 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
43 | rs533309689 | chr7:109621791-109621792 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
44 | rs138439613 | chr7:109621797-109621798 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
45 | rs181277564 | chr7:109621807-109621808 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
46 | rs374148474 | chr7:109621815-109621816 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
47 | rs73716023 | chr7:109621823-109621824 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
48 | rs115234694 | chr7:109621838-109621839 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
49 | rs186696609 | chr7:109621842-109621843 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
50 | rs12113923 | chr7:109621848-109621849 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
Disease | PMID | Source |
---|---|---|
Esophageal squamous carcinoma | 21637470 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Thyroid cancer | 19087340 | CNVD |
Seminomas | 18059402 | CNVD |
Testicular cancer | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Autism | 19415332 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
T-cell lymphomas | 19863542 | CNVD |
Malaria | 21533027 | CNVD |
Melanoma | 18172304 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
head and neck squamous cell carcinoma | 19289630 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Ewing''s sarcoma | 17952124 | CNVD |
Autism | 22495311 | CNVD |
Wilms tumour | 21544195 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Squamous cell cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Astrocytoma | 17387387 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Low-grade fibromyxoid sarcoma | 0 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Breast cancer | 21264507 | CNVD |
Shwachman-Diamond syndrome | 22934832 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Cutaneous malignant melanoma | 17690212 | CNVD |
Leukemia | 17361228 | CNVD |
Breast cancer | 16461572 | CNVD |
Peripheral t-cell lymphoma | 19118030 | CNVD |
Malignant melanoma | 17690212 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute promyelocytic leukemia | 19109227 | CNVD |
Multiple myeloma | 17550852 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
abortions and stillbirths | 19751515 | CNVD |
Acute lymphoblastic leukemia | 21980252 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Lung cancer | 18438408 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
Burkitt''s lymphoma | 19759907 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Breast cancer | 21785460 | CNVD |
Chronic myeloid leukemia | 21384125 | CNVD |
Breast cancer | 21858162 | CNVD |
Acute lymphoblastic leukemia | 22237106 | CNVD |
Breast cancer | 21364760 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Prostate cancer | 16573809 | CNVD |
Medulloblastoma | 16783165 | CNVD |
Melanoma | 17363583 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
Breast cancer | 16397240 | CNVD |
Biliary cancer | 19435499 | CNVD |
Non-small cell lung cancer | 21829676 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Prostate cancer | 23792589 | CNVD |
Adenocarcinoma | 21044232 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Autism | 19401682 | CNVD |
Non-small cell lung cancer | 19889201 | CNVD |
Acute myeloid leukemia | 18000384 | CNVD |
Esophageal adenocarcinoma | 18820669 | CNVD |
Metastatic melanoma | 18483359 | CNVD |
Autism | 18414403 | CNVD |
Autism | 19546859 | CNVD |
Schizophrenia | 19546859 | CNVD |
Tourette syndrome | 19546859 | CNVD |
Melanoma | 19188590 | CNVD |
small cell lung cancer | 20016488 | CNVD |
low-grade B-cell lymphoma tumor | 18367492 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr7:109620600-109621200 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
2 | chr7:109620800-109621200 | Enhancers | H1 Cell Line | embryonic stem cell |
3 | chr7:109620800-109621200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr7:109620800-109621400 | Enhancers | HUES48 Cell Line | embryonic stem cell |
5 | chr7:109621000-109621400 | Enhancers | iPS-15b Cell Line | embryonic stem cell |
6 | chr7:109621200-109622200 | Weak transcription | H1 Cell Line | embryonic stem cell |
7 | chr7:109621200-109622200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
8 | chr7:109622200-109622600 | ZNF genes & repeats | H1 Cell Line | embryonic stem cell |
9 | chr7:109622200-109622600 | ZNF genes & repeats | ES-UCSF4 Cell Line | embryonic stem cell |
10 | chr7:109622200-109622800 | ZNF genes & repeats | iPS-20b Cell Line | embryonic stem cell |
11 | chr7:109622800-109623200 | Weak transcription | iPS-20b Cell Line | embryonic stem cell |
12 | chr7:109623200-109623400 | Enhancers | iPS-20b Cell Line | embryonic stem cell |
13 | chr7:109624800-109625200 | Enhancers | NHEK | skin |
14 | chr7:109624800-109625400 | Enhancers | Foreskin Keratinocyte Primary Cells skin03 | Skin |
15 | chr7:109626400-109627200 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
16 | chr7:109626600-109627000 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
17 | chr7:109627600-109628800 | Enhancers | Fetal Heart | heart |
18 | chr7:109635600-109636000 | Enhancers | H9 Derived Neuron Cultured Cells | ES cell derived |
19 | chr7:109635600-109636200 | Enhancers | H9 Derived Neuronal Progenitor Cultured Cells | ES cell derived |
20 | chr7:109639200-109639800 | ZNF genes & repeats | Dnd41 | blood |
21 | chr7:109639800-109641600 | Weak transcription | Dnd41 | blood |